Consolidated Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Assets:
Cash and cash equivalents	$ 17,926,000	$ 25,993,000
Restricted cash	50,000	52,000
Certificates of deposit	1,757,000	0
Loans receivable, net of allowance for loan losses of $1,523 and $1,393 as of September 30, 2020 and December 31, 2019, respectively	119,833,000	128,843,000
Accrued interest receivable	835,000	635,000
Investment in joint venture	889,000	891,000
Property and equipment, net	232,000	216,000
Foreclosed assets, net	301,000	301,000
Servicing assets	148,000	100,000
Other assets	997,000	990,000
Total assets	142,968,000	158,021,000
Liabilities:
Term-debt	52,544,000	71,427,000
Investor notes payable, net of debt issuance costs of $25 and $55 as of September 30, 2020 and December 31 2019, respectively	75,292,000	73,046,000
Accrued interest payable	301,000	266,000
Other liabilities	1,999,000	2,211,000
Total liabilities	130,136,000	146,950,000
Members' Equity:
Series A preferred units, 1,000,000 units authorized, 117,100 units issued and outstanding at September 30, 2020 and December 31, 2019 (liquidation preference of $100 per unit); See Note 13	11,715,000	11,715,000
Class A common units, 1,000,000 units authorized, 146,522 units issued and outstanding at September 30, 2020 and December 31, 2019; See Note 13	1,509,000	1,509,000
Accumulated deficit	(392,000)	(2,153,000)
Total members' equity	12,832,000	11,071,000
Total liabilities and members' equity	$ 142,968,000	$ 158,021,000